About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT03792854

Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)

Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with defi...

Lead sponsor: Ludwig-Maximilians - University of Munich•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Falk Roeder, MD

CONTACT

+49894400 falk.roeder@t-online.de

Sabine Gerum, MD

CONTACT

+49894400 sabine.gerum@med.uni-muenchen.de

Sponsors

Lead Sponsor

Ludwig-Maximilians - University of Munich

Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with definitive chemoradiation for anal cancer. Qol will be evaluated by standardized EORTC questionaires QLQ C30 and QLQ CR29. Acute and late toxicity will be assessed according to CTCAE 4.03. Oncological outcome will be assessed with regard to local and distant control, patterns of recurrence, freedom from treatment failure and overall survival. Correlations of physicians- and patients-assessed functional outcomes are planned.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•histologically proven anal cancer without distant metastases
•indication for definitive chemoradiation therapy based on multidisciplinary evaluation
•age \>=18 years
•written informed consent
•ability to answer the standardized questionaires according to the treating physician

Exclusion Criteria

•age \< 18 years
•prior systemic therapy with regard to anal cancer
•distant metastases
•second malignancy

Related studies

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myopia and Cerebral Visual Impairment Among Youth

NCT07653074 · Myopia, Quality of Life

RECRUITINGPhase 1/2

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

NCT05639972 · HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, and more

Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer

NCT06355050 · Prostate Cancer, Adaptive Radiotherapy, and more

Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients

NCT06141798 · Age Problem, Dialysis; Complications, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 3, 2019Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment100

Start dateDec 2018

Last updatedJan 3, 2019

Condition

Anal Cancer Quality of Life Chemoradiation

Locations shown

Department of Radiation Oncology, University Hospital, LMU Munich

Munich, Bavaria

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 3, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions